Good morning :)
Place Order
Add to Watchlist

Mastek Ltd

MASTEK

Mastek Ltd

MASTEK
Information TechnologyIT Services & Consulting
SmallcapWith a market cap of ₹8,165 cr, stock is ranked 621
Moderate RiskStock is 2.70x as volatile as Nifty
2,660.000.71% (+18.80)
2,660.000.71% (+18.80)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Information TechnologyIT Services & Consulting
SmallcapWith a market cap of ₹8,165 cr, stock is ranked 621
Moderate RiskStock is 2.70x as volatile as Nifty

How to use scorecard? Learn more

Information TechnologyIT Services & Consulting
SmallcapWith a market cap of ₹8,165 cr, stock is ranked 621
Moderate RiskStock is 2.70x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
27.063.910.72%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.709.411.62%

Forecast & Ratings

Detailed Forecast 
67%
Analysts have suggested that investors can buy this stock

from 6 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Mastek Limited is an IT solutions provider. The Company's portfolio includes business and technology services, which consists of IT consulting, application development, systems integration, data warehousing, application security and CRM services.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 23.32%, vs industry avg of 11.55%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.23% to 0.39%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 24.23%, vs industry avg of 8.38%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue544.83572.76838.201,076.461,114.721,749.772,219.922,644.453,070.803,160.27
Raw Materialssubtract0.000.000.000.000.000.000.000.000.002,640.92
Power & Fuel Costsubtract4.083.853.342.802.501.991.982.612.84
Employee Costsubtract281.13323.24480.94587.17584.14882.721,095.451,376.751,670.91
Selling & Administrative Expensessubtract182.20159.95209.72285.76293.70402.34531.70637.19750.98
Operating & Other expensessubtract44.3727.9623.5543.8661.7970.3492.20108.44125.50
Depreciation/Amortizationsubtract16.0514.9318.7617.3524.8944.9542.8767.3789.9190.27
Interest & Other Itemssubtract0.503.775.866.133.628.107.6824.7244.4744.60
Taxes & Other Itemssubtract2.756.6526.0731.9235.22129.98152.91134.3685.9082.78
EPS6.0413.9829.7342.5845.1184.55106.8397.6198.6897.81
DPS2.503.506.008.508.0014.5019.0019.0019.0019.00
Payout ratio0.410.250.200.200.180.170.180.190.190.19

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Apr 29PDF
Apr 29PDF
Feb 2PDF
+3 more
FY 2022

Annual report

PDF

Investor Presentation

Apr 20PDF
Jul 19PDF
FY 2023

Annual report

PDF

Investor Presentation

Apr 19PDF
FY 2024

Annual report

PDF

Investor Presentation

Jul 19PDF
 

Peers & Comparison

Comparing 3 stocks from 
Information TechnologyIT Services & Consulting

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Mastek Ltd27.193.910.72%
Tata Consultancy Services Ltd33.8517.021.70%
Infosys Ltd30.078.922.41%
HCL Technologies Ltd31.317.202.87%

Price Comparison

Compare MASTEK with any stock or ETF
Compare MASTEK with any stock or ETF
MASTEK
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding36.25%2.20%4.91%14.04%42.60%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun13.14%13.42%13.93%14.10%14.40%14.04%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Mastek Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Tata Digital India Fund Direct Plan Growth

Growth
1.3427%0.91%-0.05%18/39 (0)
ICICI Prudential Technology Fund - Growth - Direct Plan

Growth
0.6783%0.39%-0.02%36/75 (0)
ICICI Prudential Smallcap Fund - Growth - Direct Plan

Growth
0.5277%0.49%0.49%86/111 (+12)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

MASTEK has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.72%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.18 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 17, 2024

Final
Final | Div/Share: ₹12.00

Dividend/Share

₹12.00

Ex DateEx Date

Sep 17, 2024

Cash Dividend

Ex DateEx DateJan 25, 2024

Interim
Interim | Div/Share: ₹7.00

Dividend/Share

₹7.00

Ex DateEx Date

Jan 25, 2024

Cash Dividend

Ex DateEx DateSep 18, 2023

Final
Final | Div/Share: ₹12.00

Dividend/Share

₹12.00

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateFeb 1, 2023

Interim
Interim | Div/Share: ₹7.00

Dividend/Share

₹7.00

Ex DateEx Date

Feb 1, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹12.00

Dividend/Share

₹12.00

Ex DateEx Date

Sep 8, 2022

News & Opinions
Corporate
Mastek announces strategic partnership with Onyx Health

Mastek announced a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions. This collaboration aims to expedite the adoption of FHIR (Fast Healthcare Interoperability Resources) standards, driving enhanced data interoperability and ultimately better health outcomes for patients. In an era where seamless data exchange is critical for effective healthcare delivery, the partnership between Mastek and Onyx Health will provide health plans with an out-of-the-box compliance solution for CMS-9115 (Patient Access API) and CMS-0057 (Advancing Interoperability and Electronic Prior Auth) rules. These regulations, pivotal to modernizing healthcare data exchange, require health plans to ensure secure, standardized data sharing across systems. Mastek and Onyx Health are at the forefront of delivering comprehensive solutions to meet these stringent regulatory requirements efficiently and effectively.  Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mastek schedules AGM

Mastek announced that the 42th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mastek fixes record date for final dividend

Mastek has fixed 18 September 2024 as record date to determine the Members eligible to receive the final dividend. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mastek CEO resigns

Mastek announced the resignation of Hiral Chandrana, Chief Executive Office of the company and Group CEO with effect from 07 August 2024. Powered by Capital Market - Live

1 month agoCapital Market - Live
'We Are Really Happy With Our Quarterly Performance': Mastek CFO On Q1 Results
2 months agoNDTV Profit
Mastek Q1: Margins Miss Estimate; Order Delays Weigh On Margins | Arun Agarwal | Business News
2 months agoET NOW
Profit Was Impacted By A One-Off In The West Asia Business: Mastek | CNBC TV18
2 months agoCNBC-TV18

Mastek consolidated net profit rises 2.01% in the June 2024 quarter

2 months agoBusiness Standard

Mastek Q1 PAT drops 24% QoQ to Rs 71 cr

2 months agoBusiness Standard

Mastek shares drop 4% after margins, profits slide in Q1FY25 results

2 months agoBusiness Standard